Dave Knapp

Dave Knapp, an independent journalist and community leader, shares his compelling journey with obesity and type 2 diabetes while exploring GLP-1 receptor agonists. He discusses the FDA’s crackdown on compounding pharmacies and its implications for access to these vital medications. Knapp reveals how Pharmacy Benefit Managers manipulate drug prices, making health access more difficult. Additionally, he challenges traditional weight loss methods and highlights the urgency of addressing metabolic health issues in our communities.